The health sector has not escaped from the digital transition. 3D Printer, Big data, connected objects (IOT), Nano & medical biotechnologies are now in the daily lives of industrials in this sector. More than a phenomenon, these pharmaceutical groups and the stakeholders of this ecosystem are the beginning of a new era of personalized medicine.
The progress made over the past decade in genetics, medical imaging, biology, etc., is transforming the entire medical process. The innovations no longer only concern the treatment itself, but also aims to predict, treat and manage pathologies.
Theorized by the scientific Leroy Hood, we now refer to it as 4P Medicine! He described it as follows:
- ? Predictive : from the patient’s environment , lifestyle and genetic profile, assessing the risk of exposure to certain diseases;
- ? Preventive : proposing solutions to the patient in order to limit the development of diseases;
- ? Personalized : proposing individualized treatments based on the biological and the genetic specificities of the patient as well as his profile;
- ? Participatory : involving the individual to take an active role in his own health.
These changes oblige manufacturers to upgrade the tools and technologies of diagnostics, as well as the medical devices and it therefore requires new skills ( IT teams in the biology department, data scientists, etc).
ARROWMAN Key Insights
The research for new collaborators to work on these kinds of research projects is complex. The challenge is to make very technically different worlds coincide.
In order to achieve this, Marie -Jo Villegas recommends you to precisely define the needed skills as well as the ecosystem in which they will evolve. The technical expertise of a new employee is obviously essential, but the key to success also lies in his ability to integrate a team and to interact with his environment while expanding his skills.
Marie-Jo VILLEGAS is one of the Directors of ARROWMAN Executive Search, Expert of Life Sciences and Health.